17-HYDROXYPROGESTERONE (17-OHP) - NEONATAL SCREENING - ANVISA Registration 80047580220

Access comprehensive regulatory information for 17-HYDROXYPROGESTERONE (17-OHP) - NEONATAL SCREENING in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80047580220 and manufactured by MBIOLOG DIAGNOSTICOS LTDA. The registration is held by MBIOLOG DIAGNÓSTICOS LTDA with validity until Feb 14, 2034.

This page provides complete technical specifications for this device, regulatory compliance details, 3 companies making the same product including WALLAC OY, LABSYSTEMS DIAGNOSTICS OY, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.